These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 29191162)

  • 1. Severe congenital microcephaly with 16p13.11 microdeletion combined with NDE1 mutation, a case report and literature review.
    Tan L; Bi B; Zhao P; Cai X; Wan C; Shao J; He X
    BMC Med Genet; 2017 Dec; 18(1):141. PubMed ID: 29191162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deletion 16p13.11 uncovers NDE1 mutations on the non-deleted homolog and extends the spectrum of severe microcephaly to include fetal brain disruption.
    Paciorkowski AR; Keppler-Noreuil K; Robinson L; Sullivan C; Sajan S; Christian SL; Bukshpun P; Gabriel SB; Gleeson JG; Sherr EH; Dobyns WB
    Am J Med Genet A; 2013 Jul; 161A(7):1523-30. PubMed ID: 23704059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenotypic spectrum of NDE1-related disorders: from microlissencephaly to microhydranencephaly.
    Abdel-Hamid MS; El-Dessouky SH; Ateya MI; Gaafar HM; Abdel-Salam GMH
    Am J Med Genet A; 2019 Mar; 179(3):494-497. PubMed ID: 30637988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical and genetic study of a child with mental retardation and multiple congenital anomalies and a 16p13.11 microdeletion].
    Wang H; Xiao B; Ye H; Hu Q; Qiu W
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2016 Aug; 33(4):485-9. PubMed ID: 27455003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel NDE1 homozygous mutation resulting in microhydranencephaly and not microlyssencephaly.
    Guven A; Gunduz A; Bozoglu TM; Yalcinkaya C; Tolun A
    Neurogenetics; 2012 Aug; 13(3):189-94. PubMed ID: 22526350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a de novo microdeletion 1q44 in a patient with hypogenesis of the corpus callosum, seizures and microcephaly - A case report.
    Westphal DS; Andres S; Beitzel KI; Makowski C; Meitinger T; Hoefele J
    Gene; 2017 Jun; 616():41-44. PubMed ID: 28336463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuropathology of 16p13.11 deletion in epilepsy.
    Liu JY; Kasperavičiūtė D; Martinian L; Thom M; Sisodiya SM
    PLoS One; 2012; 7(4):e34813. PubMed ID: 22523559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new microdeletion syndrome involving TBC1D24, ATP6V0C, and PDPK1 causes epilepsy, microcephaly, and developmental delay.
    Mucha BE; Banka S; Ajeawung NF; Molidperee S; Chen GG; Koenig MK; Adejumo RB; Till M; Harbord M; Perrier R; Lemyre E; Boucher RM; Skotko BG; Waxler JL; Thomas MA; Hodge JC; Gecz J; Nicholl J; McGregor L; Linden T; Sisodiya SM; Sanlaville D; Cheung SW; Ernst C; Campeau PM
    Genet Med; 2019 May; 21(5):1058-1064. PubMed ID: 30245510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Refining the phenotype associated with CASC5 mutation.
    Saadi A; Verny F; Siquier-Pernet K; Bole-Feysot C; Nitschke P; Munnich A; Abada-Dendib M; Chaouch M; Abramowicz M; Colleaux L
    Neurogenetics; 2016 Jan; 17(1):71-8. PubMed ID: 26626498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NDE1-related disorders: A recurrent NDE1 pathogenic variant causing Lissencephaly 4 can also be associated with microhydranencephaly.
    Bas H; Saylisoy S; Cilingir O; Gokalp EE; Kocagil S; Yarar C; Aras BD; Artan S
    Am J Med Genet A; 2022 Jan; 188(1):326-331. PubMed ID: 34562061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SLC1A4 mutations cause a novel disorder of intellectual disability, progressive microcephaly, spasticity and thin corpus callosum.
    Heimer G; Marek-Yagel D; Eyal E; Barel O; Oz Levi D; Hoffmann C; Ruzzo EK; Ganelin-Cohen E; Lancet D; Pras E; Rechavi G; Nissenkorn A; Anikster Y; Goldstein DB; Ben Zeev B
    Clin Genet; 2015 Oct; 88(4):327-35. PubMed ID: 26138499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human mutations in NDE1 cause extreme microcephaly with lissencephaly [corrected].
    Alkuraya FS; Cai X; Emery C; Mochida GH; Al-Dosari MS; Felie JM; Hill RS; Barry BJ; Partlow JN; Gascon GG; Kentab A; Jan M; Shaheen R; Feng Y; Walsh CA
    Am J Hum Genet; 2011 May; 88(5):536-47. PubMed ID: 21529751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Both rare and de novo copy number variants are prevalent in agenesis of the corpus callosum but not in cerebellar hypoplasia or polymicrogyria.
    Sajan SA; Fernandez L; Nieh SE; Rider E; Bukshpun P; Wakahiro M; Christian SL; Rivière JB; Sullivan CT; Sudi J; Herriges MJ; Paciorkowski AR; Barkovich AJ; Glessner JT; Millen KJ; Hakonarson H; Dobyns WB; Sherr EH
    PLoS Genet; 2013; 9(10):e1003823. PubMed ID: 24098143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A 2.0 Mb microdeletion in proximal chromosome 14q12, involving regulatory elements of FOXG1, with the coding region of FOXG1 being unaffected, results in severe developmental delay, microcephaly, and hypoplasia of the corpus callosum.
    Takagi M; Sasaki G; Mitsui T; Honda M; Tanaka Y; Hasegawa T
    Eur J Med Genet; 2013 Sep; 56(9):526-8. PubMed ID: 23895774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Case report of novel DYRK1A mutations in 2 individuals with syndromic intellectual disability and a review of the literature.
    Luco SM; Pohl D; Sell E; Wagner JD; Dyment DA; Daoud H
    BMC Med Genet; 2016 Feb; 17():15. PubMed ID: 26922654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severe NDE1-mediated microcephaly results from neural progenitor cell cycle arrests at multiple specific stages.
    Doobin DJ; Kemal S; Dantas TJ; Vallee RB
    Nat Commun; 2016 Aug; 7():12551. PubMed ID: 27553190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 16p13.11 microduplication in 45 new patients: refined clinical significance and genotype-phenotype correlations.
    Allach El Khattabi L; Heide S; Caberg JH; Andrieux J; Doco Fenzy M; Vincent-Delorme C; Callier P; Chantot-Bastaraud S; Afenjar A; Boute-Benejean O; Cordier MP; Faivre L; Francannet C; Gerard M; Goldenberg A; Masurel-Paulet A; Mosca-Boidron AL; Marle N; Moncla A; Le Meur N; Mathieu-Dramard M; Plessis G; Lesca G; Rossi M; Edery P; Delahaye-Duriez A; De Pontual L; Tabet AC; Lebbar A; Suiro L; Ioos C; Natiq A; Chafai Elalaoui S; Missirian C; Receveur A; François-Fiquet C; Garnier P; Yardin C; Laroche C; Vago P; Sanlaville D; Dupont JM; Benzacken B; Pipiras E
    J Med Genet; 2020 May; 57(5):301-307. PubMed ID: 30287593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fetal brain disruption sequence versus fetal brain arrest: A distinct autosomal recessive developmental brain malformation phenotype.
    Abdel-Salam GM; Abdel-Hamid MS; El-Khayat HA; Eid OM; Saba S; Farag MK; Saleem SN; Gaber KR
    Am J Med Genet A; 2015 May; 167A(5):1089-99. PubMed ID: 25755095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The essential role of centrosomal NDE1 in human cerebral cortex neurogenesis.
    Bakircioglu M; Carvalho OP; Khurshid M; Cox JJ; Tuysuz B; Barak T; Yilmaz S; Caglayan O; Dincer A; Nicholas AK; Quarrell O; Springell K; Karbani G; Malik S; Gannon C; Sheridan E; Crosier M; Lisgo SN; Lindsay S; Bilguvar K; Gergely F; Gunel M; Woods CG
    Am J Hum Genet; 2011 May; 88(5):523-35. PubMed ID: 21529752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel mutations c.28G>T (p.Ala10Ser) and c.189G>T (p.Glu63Asp) in WDR62 associated with early onset acanthosis and hyperkeratosis in a patient with autosomal recessive microcephaly type 2.
    Banerjee S; Chen H; Huang H; Wu J; Yang Z; Deng W; Chen D; Deng J; Su Y; Li Y; Wu C; Wang Y; Zeng H; Wang Y; Li X
    Oncotarget; 2016 Nov; 7(48):78363-78371. PubMed ID: 27852057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.